Pazopanib Terminated Phase 4 Trials for metastatic Clear Cell Renal Cell Carcinoma (ccRCC) Basic Science

IndicationsStatusPurposePhase
TerminatedBasic Science4
clinicaltrials.gov IdentifierTitleDrugs
NCT02570789Evaluation of Predictive Markers for Toxicity and Efficacy in Patients With mccRCC Treated by Anti-VEGF Therapy